Epstein Secrets

story.html> (7/30, Marimow, I4.2M) reports that on Thursday, the full US Court of Appeals for the DC Circuit "agreed...to revisit US District Judge Emmet G. Sullivan's plan to examine" the Justice Department's decision to drop its case against former national security adviser Michael Flynn, thereby "reviving the un

rts to develop "an antibody for covid-19. `We have been thinking about and preparing for this for a long time, and it's almost a bit surreal,' said Amy Jenkins, manager of DARPA's antibody program, which is known as the Pandemic Prevention Platform, or P3." According to the Post, "In that program and others

hington Post (7/30, Marimow, 14.2M) reports that on Thursday, the full US Court of Appeals for the DC Circuit "agreed...to revisit US District Judge Emmet G. Sullivan's plan to examine" the Justice Department's decision to drop its case against former national security adviser Michael Flynn, thereby "reviving the u

to develop "an antibody for covid-19. ... 'We have been thinking about and preparing for this for a long time, and it's almost a bit surreal,' said Amy Jenkins, manager of DARPA's antibody program, which is known as the Pandemic Prevention Platform, or P3." According to the Post, "In that program and other

hington Post (7/30, Marimow, 14.2M) reports that on Thursday, the full US Court of Appeals for the DC Circuit "agreed...to revisit US District Judge Emmet G. Sullivan's plan to examine" the Justice Department's decision to drop its case against former national security adviser Michael Flynn, thereby "reviving the u

to develop "an antibody for covid-19. ... 'We have been thinking about and preparing for this for a long time, and it's almost a bit surreal,' said Amy Jenkins, manager of DARPA's antibody program, which is known as the Pandemic Prevention Platform, or P3." According to the Post, "In that program and other